Fulgent Genetics, Inc.
FLGT
$20.31
-$0.21-1.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 75.43% | 74.55% | -159.76% | -235.71% | -540.33% |
| Total Depreciation and Amortization | -6.72% | -4.65% | -14.09% | -21.47% | -25.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -71.77% | -72.22% | 157.15% | 208.14% | 157.54% |
| Change in Net Operating Assets | -274.92% | -354.80% | -184.34% | -91.11% | 171.25% |
| Cash from Operations | -77.80% | -22.01% | -75.76% | -34.20% | -26.27% |
| Capital Expenditure | -69.12% | -81.54% | -66.41% | -2.85% | -56.83% |
| Sale of Property, Plant, and Equipment | -93.17% | -59.61% | 5.88% | -22.17% | 40.10% |
| Cash Acquisitions | -- | -- | 98.86% | 98.86% | 99.77% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 189.46% | -130.22% | 265.19% | 524.32% | 125.19% |
| Cash from Investing | 521.02% | -250.01% | 91.50% | 108.31% | 98.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 92.84% | 91.13% | 80.20% | 68.70% | -2,351.25% |
| Issuance of Common Stock | 1,600.00% | 1,600.00% | -100.00% | -100.00% | -80.00% |
| Repurchase of Common Stock | 59.13% | 88.76% | 19.08% | 55.64% | 62.30% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 73.30% | 89.86% | 40.75% | 58.29% | 35.98% |
| Foreign Exchange rate Adjustments | 110.16% | 63.09% | 139.09% | 30.00% | 43.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 210.82% | -334.84% | 69.42% | 108.41% | 95.99% |